White blood cell depletions and polymorphonuclear cell collections on the next-generation therapeutic apheresis platform to provide procedure flexibility and intuitive operation
LAKEWOOD, Colo., USA—15 July 2014—Health Canada has approved the White Blood Cell Depletion (WBCD) protocol for clinical use on the Terumo BCT Spectra Optia® system. With this availability, clinicians in Canada now have the ability to perform WBCD procedures on the next-generation therapeutic apheresis system. In addition to the WBCD protocol, Health Canada also approved the polymorphonuclear (PMN) cell collection protocol, or granulocyte collections, adding to Spectra Optia system's versatility.
KEY FACTS ABOUT SPECTRA OPTIA SYSTEM AND THE WBCD PROTOCOL:
KEY FACTS ABOUT SPECTRA OPTIA SYSTEM AND THE PMN CELL COLLECTION PROTOCOL:
KEY FACTS ABOUT SPECTRA OPTIA PROTOCOLS:
Bob Sullivan, Terumo BCT, Vice President, Therapeutic Systems
"Further strengthening the existing portfolio of protocols available for use on the Spectra Optia system in Canada, the new white blood cell depletion and granulocyte collection protocols will provide more flexibility to the customers we serve. We are excited to deliver these added treatment options for the clinicians who advance apheresis every day in the delivery of exceptional patient care."
"The protocols now available on the Spectra Optia system in Canada represent the majority of total procedures performed on the original COBE Spectra system. These new protocol offerings add value for customers transitioning to the next-generation platform."
LAKEWOOD, Colo., USA—October 21, 2016—XXXXXXXXXX
About Terumo BCT
Terumo BCT, a global leader in blood component, therapeutic apheresis and cellular technologies, is the only company with the unique combination of apheresis collections, manual and automated whole blood processing, and pathogen reduction technologies. We believe in the potential of blood to do even more for patients than it does today. This belief inspires our innovation and strengthens our collaboration with customers.
Sherri Hughes-Smith, Terumo BCT Global Integrated Communications
Products available in select markets.